SCHEMBL5571203

SCHEMBL5571203

CC(C)C1=NCCCN1c1ccc(NC(=O)C(N)c2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ ESR1 P03372 1/20 0.45
▸ NR4A1 P22736 1/20 0.45
▸ PTK2B Q14289 1/20 0.45
▸ KCNQ2 O43526 1/20 0.43
▸ ALDH1A1 P00352 6/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ BAZ1A Q9NRL2 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ ROCK2 O75116 1/20 0.41
▸ ROCK1 Q13464 1/20 0.41
▸ EIF2AK3 Q9NZJ5 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ F10 P00742 3/20 0.40
▸ CSF1R P07333 1/20 0.40
▸ MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5570502 0.87 MAPT (0.46) MAPTNPSR1KMT2AUSP2ESR1
SCHEMBL5566702 0.85 MAPT (0.46) MAPTNPSR1KMT2AUSP2ESR1
SCHEMBL5569229 0.84 MAPT (0.44) MAPTNPSR1KMT2AUSP2ESR1
SCHEMBL5569317 0.82 ALDH1A1 (0.44) MAPTNPSR1KMT2AUSP2ESR1
SCHEMBL5571210 0.80 F10 (0.51) MAPTNPSR1KMT2AUSP2ESR1
SCHEMBL5569385 0.76 KMT2A (0.48) MAPTNPSR1KMT2AUSP2ESR1
SCHEMBL5431564 0.75 MAPT (0.47) MAPTNPSR1KMT2AUSP2ESR1
SCHEMBL6718795 0.73 CRHBP (0.64) MAPTNPSR1KMT2AALDH1A1BAZ1A
SCHEMBL4834603 0.73 BAZ1A (0.41) MAPTNPSR1KMT2AUSP2ESR1
SCHEMBL4828973 0.73 BAZ1A (0.41) MAPTNPSR1KMT2AUSP2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
EP-1628668-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS Bristol-Myers Squibb Company (US) 2006-03-01 — — EP disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 — — WO disclosed
Send feedback